- Rank in Search Criteria: 1431
World Rank (Aug-2026): 7,693
World Rank (Jan-05-2024): 7,693
World Rank (Jul-30-2023): 7693
World Rank (Jan-2022): 7,693
- Rank in Search Criteria: 1432
World Rank (Aug-2026): 7,693
World Rank (Jan-05-2024): 7,693
World Rank (Jul-30-2023): 7693
World Rank (Jan-2022): 7,693
- Rank in Search Criteria: 1433
World Rank (Aug-2026): 7,693
World Rank (Jan-05-2024): 7,693
World Rank (Jul-30-2023): 7693
World Rank (Jan-2022): 7,693
- Rank in Search Criteria: 1434
World Rank (Aug-2026): 7,693
World Rank (Jan-05-2024): 7,693
World Rank (Jul-30-2023): 7693
World Rank (Jan-2022): 7,693
Headquarters Country: Spain
- Rank in Search Criteria: 1435
World Rank (Aug-2026): 7,693
World Rank (Jan-05-2024): 7,693
World Rank (Jul-30-2023): 7693
World Rank (Jan-2022): 7,693
- Rank in Search Criteria: 1436
World Rank (Aug-2026): 7,708
Market Cap (Aug-2026): 1.411 Billion USD
World Rank (Jan-05-2024): 5,440
Market Cap (Jan-05-2024): 2.15 Billion USD
World Rank (Jul-30-2023): 6762
Market Cap (Jul-30-2023): 1.54 Billion USD
World Rank (Jan-2022): 4,776
Market Cap (Jan-2022): 3.06 Billion USDAnnual Revenue in USD: 13,186 Million USD
Annual Net Income in USD: 285 Million USD
Annual Results for Period ending: Dec-2021 ending yearCompany Profile: Sistema Public Joint Stock Financial Corporation is a conglomerate investment company and it has businesses in telecommunications, electronics, tourism, trade, banking and financial services, retail, media, oil refining, construction, pharmaceuticals and real estate. The headquarters is in Russia.
- Rank in Search Criteria: 1437
World Rank (Aug-2026): 7,709
Market Cap (Aug-2026): 1.410 Billion USD
World Rank (Jan-05-2024): 5,970
Market Cap (Jan-05-2024): 1.85 Billion USD
World Rank (Jul-30-2023): 6162
Market Cap (Jul-30-2023): 1.79 Billion USD
World Rank (Jan-2022): 6,197
Market Cap (Jan-2022): 2.05 Billion USDAnnual Revenue in USD: 74 Million USD
Annual Net Income in USD: 78 Million USD
Annual Results for Period ending: Dec-2021 ending yearCompany Profile: Zug Estates Holding AG designs, develops, markets and manages real estate company. The company annual revenue is 139.8 million CHF, annual operating income is 43.7 million CHF, annual net income is 32.2 million CHF and total assets are 1,626.2 million CHF as on 2020. The headquarters is in Switzerland.
- Rank in Search Criteria: 1438
World Rank (Aug-2026): 7,711
Market Cap (Aug-2026): 1.410 Billion USD
World Rank (Jan-05-2024): 7,032
Market Cap (Jan-05-2024): 1.41 Billion USD
World Rank (Jul-30-2023): 7361
Market Cap (Jul-30-2023): 1.34 Billion USD
World Rank (Jan-2022): 7,805
Market Cap (Jan-2022): 1.38 Billion USDCompany Profile: GasLog is a provider of LNG shipping services company. The headquarters is in Greece.
Facts About Company: GasLog company annual revenue was 915 million USD, annual operating income is 467 million USD for year ending Dec-2022..
- Rank in Search Criteria: 1439
World Rank (Aug-2026): 7,712
Market Cap (Aug-2026): 1.410 Billion USD
World Rank (Jan-05-2024): 8,759
Market Cap (Jan-05-2024): 0.97 Billion USD
World Rank (Jul-30-2023): 9765
Market Cap (Jul-30-2023): 0.82 Billion USD
World Rank (Jan-2022): 8,900
Market Cap (Jan-2022): 1.10 Billion USDAnnual Revenue in USD: 945 Million USD
Annual Operating Income in USD: -55 Million USD
Annual Net Income in USD: -66 Million USD
Annual Results for Period ending: Dec-2022 ending yearCompany Profile: Elementis is a global specialty chemicals company that offers performance driven additives that help create innovative formulations for consumer and industrial applications. The company annual revenue is 751 million USD and total assets are 1,835.6 million USD as on 2020. The headquarters is in UK.
- Rank in Search Criteria: 1440
World Rank (Aug-2026): 7,733
Market Cap (Aug-2026): 1.402 Billion USD
World Rank (Jan-05-2024): 3,968
Market Cap (Jan-05-2024): 3.40 Billion USD
World Rank (Jul-30-2023): 4196
Market Cap (Jul-30-2023): 3.16 Billion USD
Company Profile: MOONLAKE IMMUNOTHERAPEUTICS is a clinical stage biopharmaceutical company with the novel investigational Nanobody for the treatment of inflammation to revolutionize outcomes for patients. The headquarters is in Switzerland.